Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients

Documents similaires

• Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
  par: Shimizu, Yoshie, et autres
  Publié: (2015)
• Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
  par: Inoue, Kenji, et autres
  Publié: (2015)
• Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
  par: Nakakura, Shunsuke, et autres
  Publié: (2012)
• Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
  par: Lorenz, Katrin, et autres
  Publié: (2011)
• Efficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practice
  par: Lanzl, Ines, et autres
  Publié: (2011)